-
Precision Oncology
Revolutionizing the way that cancer is monitored and treated in our region and beyond
The QEII is a national leader and centre of excellence in personalized cancer care. This $6.2-million project will equip our experts with the precision oncology tools they need to deliver some of the country’s most leading-edge cancer care available.
What donors will make possible
Through our We Are campaign, we’re committed to funding the most advanced, forward-thinking care that only philanthropy can make possible — impacting the thousands of Atlantic Canadian cancer patients and families who rely on the QEII each year.
Here’s some of the key benefits when you support this project:
![](/sites/default/files/inline-images/Asset%206%403x.png)
Identifying more targeted and effective treatment options, tailored to patients’ specific cancer
![](/sites/default/files/styles/thumbnail/public/2023-09/Earlier%20detection.png)
Detecting cancer and cancer recurrence earlier, ultimately improving survival rates
![](/sites/default/files/inline-images/Asset%203%403x_0.png)
Sparing patients from treatments they likely won’t respond to and harmful side effects
![](/sites/default/files/styles/thumbnail/public/2023-06/Participating-hospitals-icon-150.png)
Positioning the QEII as a national leader and centre of excellence in precision oncology
![](/sites/default/files/styles/thumbnail/public/2023-09/Enhancing.png)
Unlocking access to more clinical trials and research opportunities by having access to these groundbreaking precision oncology tools
![](/sites/default/files/styles/thumbnail/public/2023-05/Immediate-Impact.png)
Reducing wait times and costs on the healthcare system as fewer biopsies and cancer treatments, like chemotherapy, are expected
![](/sites/default/files/styles/thumbnail/public/2023-09/Recruit.png?itok=5cAqh7im)
Recruiting and retaining top medical talent with the most advanced technology and treatment methods available